Cafepharma Today

September 19 2024 - Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Havas Lynx explores pharma marketers’ role in addressing climate health crisis
Roche reports positive data from Phase III influenza treatment trial
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Forest Labs hits 7-year low on trial results
Yahoo/AP
Thursday, September 4, 2008 - 8:24am
tags:
Sciele Target the Buyout Price
Yahoo/Zacks.com
Thursday, September 4, 2008 - 8:22am
tags:
Cephalon ending Provigil promotion deal with Takeda
Bizjournals.com
Thursday, September 4, 2008 - 8:22am
tags:
FTC seeks more information on Teva's Barr takeover
Yahoo/AP
Thursday, September 4, 2008 - 8:21am
tags:
Daiichi Sankyo reports positive data for anticoagulant drug
Pharmaceutical Business Review
Thursday, September 4, 2008 - 8:20am
tags:
Akorn-Strides wins approval for two new drugs
Pharmaceutical Business Review
Thursday, September 4, 2008 - 8:18am
tags:
Merck KGaA, Ablynx sign up to $484 mln drug deal
Forbes
Thursday, September 4, 2008 - 8:17am
tags:
Top Statistician Says Vytorin Cancer Risk 'Not Ruled Out'
Forbes
Thursday, September 4, 2008 - 8:16am
tags:
Pfizer staking millions on Alzheimer's hunch
The Day, CT
Thursday, September 4, 2008 - 8:16am
tags:
Epix regains rights to MRA agent from Bayer
Marketwatch
Thursday, September 4, 2008 - 8:15am
tags:
A Win For Regeneron
Forbes
Thursday, September 4, 2008 - 8:12am
tags:
Flash: Vytorin Study Not A Conspiracy
Forbes
Thursday, September 4, 2008 - 8:11am
tags:
UCB Pharma to Rebrand as Specialty Company
PharmExec
Thursday, September 4, 2008 - 8:08am
tags:
Forest Labs, Almirall report on studies of COPD drug
Marketwatch
Wednesday, September 3, 2008 - 11:18am
tags:
Cyclacel Pharma in Early Cycle
Yahoo/Zacks.com
Wednesday, September 3, 2008 - 11:16am
tags:
Exelixis: A Platform Company for Oncology
Seeking Alpha
Wednesday, September 3, 2008 - 11:16am
tags:
Vertex Pharma downgraded to 'Perform' as analyst says stock will stay at recent levels
Yahoo/AP
Wednesday, September 3, 2008 - 11:14am
tags:
Were Vytorin Cancer Data Made Public Too Soon?
WSJ Online
Wednesday, September 3, 2008 - 9:03am
tags:
Pfizer paying up to $725 million for Alzheimer drug rights
Marketwatch
Wednesday, September 3, 2008 - 8:52am
tags:
Novartis: Tekturna better than diuretic for obese patients
Marketwatch
Wednesday, September 3, 2008 - 8:48am
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

FDA Approves Fasenra for Eosinophilic Granulomatosis with Polyangiitis
pharmexec
FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
pharmexec
Keytruda Demonstrates Superior Overall Survival vs. Yervoy in Advanced Melanoma
pharmexec
CAR-T For Autoimmune Disorders
In the Pipeline
A Better Response to Inflammation: Q&A with Dr. Ira Spector
pharmexec
Braftovi Plus Mektovi Demonstrates Sustained Efficiency in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
pharmexec
GSK Launches Brooke Shields’ Led Campaign Promoting Shingles Vaccine
pharmexec
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
pharmexec
Pharmaceutical Executive: September 2024 Issue (PDF)
pharmexec

Latest Jobs

Account Manager-Los Angeles-Ophthalmics
Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Regional Sales Manager - Eyecare - East Region
Miami, Florida, 33222
PV8 US Innovex Inc.
Business Development Manager- Tampa, Florida
Tampa, Florida, 33646
Hanger Clinic
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
Territory Account Associate- Grand Rapids, MI
Grand Rapids, Michigan, 49528
Amplity Health
Surgical Solutions Field Sales Associate - Remote
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Manager, Business Development - Physician Relations - Days - Full-Time
Baton Rouge, Louisiana, 70873
Woman's Hospital
Area Business Manager - Pulmonology - Greenville, SC
Asheville, North Carolina, 28814
Sanofi
Area Manager, Specialty Atlantic Region
Fields, Oregon, 97710
CSL Behring
Territory Manager (PCP) (Madison, AL)
Huntsville, Alabama, 35824
Bausch Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information